United States - English - NLM (National Library of Medicine)

a-s medication solutions - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.      pediatric use. safety and effectiveness in children have not been established. (see contraindications)

United States - English - NLM (National Library of Medicine)

a-s medication solutions - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater s

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life. geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater se

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients,

United States - English - NLM (National Library of Medicine)

rebel distributors corp - silver sulfadiazine (unii: w46jy43ejr) (silver sulfadiazine - unii:w46jy43ejr) - silver sulfadiazine 10 mg in 1 g - thermazene® (silver sulfadiazine) cream, 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. thermazene cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, thermazene cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc - silver sulfadiazine (unii: w46jy43ejr) (silver sulfadiazine - unii:w46jy43ejr) - silver sulfadiazine 10 mg in 1 g - thermazene® (silver sulfadiazine) cream, 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. thermazene cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, thermazene cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life. prompt institution of appropriate regimens for care of the burned patient is of prime importance and includes the control of shock and pain.  the burn wounds are then cleansed and debrided; silver sulfadiazine cream is then applied under sterile conditions.  the burn areas should be covered with silver sulfadiazine cream at all times.  the cream should be applied once to twice daily to a thickness of approximately one sixteenth of an inch.  whenever necessary, the cream should be reapplied to any areas from which it has been removed due to patient activity.  administration may be accomplished in minimal time because dressings are not required.  however, if individual patient requirements make dressings necessary, they may be used.  reapply immediately after hydrotherapy.  treatment with silver sulfadiazine cream should be continued until satisfactory healing has occurred or until the burn site is ready for grafting.  the drug should not be withdrawn from the therapeutic regimen while there remains the possibility of infection except if a significant adverse reaction occurs.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life. prompt institution of appropriate regimens for care of the burned patient is of prime importance and includes the control of shock and pain.  the burn wounds are then cleansed and debrided; silver sulfadiazine cream is then applied u

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life. prompt institution of appropriate regimens for care of the burned patient is of prime importance and includes the control of shock and pain.  the burn wounds are then cleansed and debrided; silver sulfadiazine cream is then applied u